RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:My, my.....Ithno and Ionc working overtime to trash Oncy....actually Azzak, the science as yet is still 'UNPROVEN'. It will only be indefatigable (I prefer the term unassailable) when they have trial results that are statistically significant.
ONCY had a chance to start said mBC Phase III 5 years ago, but chose not to... It has wasted so much time, and all the while MC tells us he has been doing so to ensure shareholder value.
Hmmm, well, lets see where the chips fall by year end.. There are four definite inflection points for CRPR until March 2024.
1) FDA approval for Sickle Cell
2 EMA approval for same
3) SFDA approval for same
4) FDA approval for Beta Thalassemia
and analyst targets on ONCY have been reduced to $5... so what is the upside here for the associated risk... it's pitiful
Oh yes, someone, might make an offer of partnership and/or buyout, because Matt reiterated, as he has done for 7 years, that they are in talks... LOL... Let's be honest this stock is a complete gamble. Past performance is very telling.